Wednesday, May 25, 2022
  • Hyderabad
  • Telangana
  • Andhra Pradesh
  • India
  • World
  • Entertainment
  • Science and Tech
  • Sport
  • Business
  • ...
    • NRI
    • View Point
    • cartoon
    • Columns
    • Reviews
    • Education Today
    • Property
    • Videos
    • Lifestyle
E-Paper
  • NRI
  • View Point
  • cartoon
  • Columns
  • Reviews
  • Education Today
  • Property
  • Videos
  • Lifestyle
Home | India | Russian Vaccine Arrives In India For Human Clinical Trial

Russian vaccine arrives in India for human clinical trial

By IANS
Published: Published Date - 07:05 PM, Fri - 13 November 20
Representational Image The vaccine supplies for the global market will be produced by RDIF's international partners in India, Brazil, China, South Korea and other countries.

New Delhi: The Russian ‘Sputnik V’ vaccine for Covid-19 has arrived in India following the nod to Pharma major Dr Reddy’s Laboratories to conduct an adaptive phase 2/3 human clinical trial for the vaccine in the country.

In a video that surfaced on media, containers with logos of Dr Reddy’s and Sputnik V being unloaded from a small truck was seen.

On Wednesday, Russia’s National Research Centre for Epidemiology and Microbiology and the Russian Direct Investment Fund announced that the Sputnik V vaccine demonstrated high efficacy — 92 per cent.

On September 4, The Lancet, one of world’s leading medical journals, published a research paper on the results of Phase I and Phase II clinical trials of the vaccine that showed no serious adverse events and effective immune response of those vaccinated.

Requests for more than 1.2 billion doses of Sputnik V vaccine came from over 50 countries.

The vaccine supplies for the global market will be produced by RDIF’s international partners in India, Brazil, China, South Korea and other countries.

Earlier this October, Dr Reddy’s and Russia Direct Investment Fund (RDIF) received approval from the Drugs Controller General of India (DCGI) to conduct an adaptive phase 2/3 human clinical trial for the Sputnik V vaccine in India.

“The government is committed to fast-track clinical development of COVID vaccine candidates and provide facilitation to accelerate market readiness of a suitable vaccine,” said Renu Swarup, Secretary, DBT and Chairperson, BIRAC.

On August 11, the Sputnik V vaccine developed by the Gamaleya National Research Institute of Epidemiology and Microbiology was registered by the Ministry of Health of Russia and became the world’s first registered vaccine against Covid-19 based on the human adenoviral vector platform.

  • Follow Us :
  • Tags
  • Clinical Trial
  • Corona Virus Deaths
  • Coronavirus
  • Coronavirus in India

Related News

  • Q&A session on steps to achieve success amid competition in TT, NT’s awareness programme

  • TT, NT’s awareness programme in Hanamkonda gets good response

  • Telangana buys 30 lakh tonne paddy so far

  • Sadhguru hails Telangana’s efforts to improve farm sector

  • Malnutrition: Telangana’s efforts find place in UN report

  • Hyderabad: ISB students under scanner ahead of PM’s visit, alleges CPI leader

Latest News

  • 18 children killed in Texas school shooting, Biden rages

    8 mins ago
  • Opinion: The new cold war will be fiercer

    9 hours ago
  • Editorial: Opening doors for regional cooperation

    9 hours ago
  • Cyber fraudsters swindle Rs 2.7 crore using ‘investment bait’ in Cyberabad

    9 hours ago
  • IPL 2022: Gujarat Titans qualify for final with seven-wicket win over RR

    9 hours ago
  • Nutreat offers healthy, nutritious food using traditional techniques

    10 hours ago
  • Telangana’s Lavanya makes it to Indian team for U-20 Asian Volleyball Championship

    10 hours ago
  • Think positive, improve skills experts tell aspirants in TT, NT’s awareness programme

    10 hours ago

company

  • Home
  • About Us
  • Contact Us

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

© Copyrights 2022 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam